Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02870998
Other study ID # MP-10-2016-2591
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 2016
Est. completion date November 2019

Study information

Verified date February 2019
Source Laval University
Contact Myriam Gagne, MSc
Phone 1-418-656-8711
Email myriam.gagne@criucpq.ulaval.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare the impacts of two versions of a continuing education activity targeted at COPD case managers on educational outcomes: 1) participation; 2) satisfaction; 3) learning; 4) competence; 5) performance; 6) patient health outcomes.


Description:

This study has a quasi-experimental design. The study is based on the Expanded Outcomes Framework for Planning and Assessing Continung Medical Education by Moore (2009). One groupe of participants will attend the former version of the continuing education activity, and the other group will attend its new version.

Data will be collected at T0 (before the activity, which will be held at T1); at T2 (immediately after the activity); at T3 (1-month post-activity); at T4 (2-month post-activity); at T5 (4-month post-activity); at T6 (10-month post-activity).

Participation will be assessed at T0. Satisfaction will be assessed at T2. Learning will be assessed at T0 and T3. Competence will be assessed at T2. Performance will be assessed at T4. Patient health outcomes will be assessed at T5 and T6.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date November 2019
Est. primary completion date November 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion criteria for attendees:

- Attending the continuing education activity

- Providing patient education to individuals with COPD in professional setting.

Exclusion criteria for attendees:

Inclusion criteria for COPD patients:

- Doctor-diagnosed COPD.

Exclusion criteria for attendees:

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Active learning
1-day continuing education activity consisting of a lecture on patient education.
Passive learning
1-day continuing education activity consisting of a brief lecture on patient education and workshops.

Locations

Country Name City State
Canada Institut universitaire de cardiologie et de pneumologie de Québec Quebec

Sponsors (1)

Lead Sponsor Collaborator
Laval University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Performance We will videotape patient education intervention delivered by attendees in their professional practice and will assess the quality of the delivered patient education intervention using a set a pre-defined criteria. 2-month post-intervention
Secondary Satisfaction We will measured the extent to which attendees' expectations about the continuing education activity are met, using a self-administered questionnaire. Immediately post-intervention
Secondary Learning We will measured declarative and procedural knowledge about patient education in attendees, using a validated self-administered questionnaire. Prior to and 1-month post-intervention
Secondary Competence We will measure attendees' self-reported competences in achieving learning activity objectives, using a self-administered questionnaire. Prior and immediately post-intervention
Secondary Patient health outcomes We will measured COPD patients' health-related quality of life, self-management skills, and health utilization, using validated interviewer-administered questionnaires. 4-month and 10-month post-intervention
See also
  Status Clinical Trial Phase
Completed NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Completed NCT00281216 - Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations N/A
Completed NCT00281203 - Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD N/A
Completed NCT00281190 - Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function N/A
Completed NCT00281229 - T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Completed NCT00159341 - Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 1
Completed NCT00281242 - Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Completed NCT00069823 - Study of Acid Reflux in Asthma Phase 3
Completed NCT00006513 - Assessing the Occupation Burden in COPD N/A
Completed NCT00000621 - Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) Phase 2
Completed NCT00006306 - Effects of Chronic Ozone Exposure on Lung Function N/A
Completed NCT00000569 - Lung Health Study II Phase 3
Completed NCT00005425 - Statistical Analysis of Vlagtwedde-Vlaardingen Data Set N/A
Completed NCT00005720 - Lay-Led Smoking Cessation Approach for Southeast Asian Men N/A
Completed NCT00000568 - Lung Health Study (LHS) I and III Phase 3
Completed NCT00005281 - Early Risk Predictors For Chronic Pulmonary Disease N/A
Not yet recruiting NCT05286918 - Antibiotic Stewardship in AECOPD Through CRP-Guided Management N/A
Recruiting NCT05565872 - Effects of Supervision During a Community-based Exercise Intervention (Urban Training) in Patients With COPD N/A
Not yet recruiting NCT02928666 - Integration of Guidelines for Comorbidities N/A
Completed NCT02306473 - The Leaky Lung Test Early Phase 1